US Broker Ratings

GSK plc (GSK) Stock Analysis: Evaluating a 5.90% Potential Upside Amid Healthcare Innovations

GSK plc (NYSE: GSK), a leading player in the healthcare sector, offers a compelling investment opportunity for those interested in the drug manufacturing industry. With a market capitalization of $108.66..

Novo Nordisk A/S (NVO) Stock Analysis: A Potential 13.39% Upside in Healthcare’s Heavyweight

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture investor attention with its promising potential upside of 13.39%, as highlighted by the average analyst target..

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 14% Upside Potential in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a stalwart in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization of $21.63 billion,..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 17.54% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a leader in the healthcare sector, specifically in diagnostics and research, boasts a market capitalization of $21.74 billion. The company is strategically positioned in the..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unpacking the 46.95% Potential Upside for Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a pioneering force in the biotechnology sector, specializing in the innovative field of ribonucleic acid interference (RNAi) therapeutics. With a substantial market capitalization..

IDEXX Laboratories (IDXX) Stock Analysis: A 29.6% Upside in the Booming Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable force in the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $45.06 billion, the company’s..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Unveiling a 16.82% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a pioneering force in the biotechnology sector, is garnering significant attention from investors seeking robust growth and solid financial performance. With its market capitalization standing..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating Growth Potential and Analyst Consensus

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $24.86 billion, the..

Baxter International (BAX) Stock Analysis: Exploring a 21.78% Potential Upside in Healthcare Innovation

For investors with a keen eye on the healthcare sector, Baxter International Inc. (NYSE: BAX) presents an intriguing opportunity. Despite recent challenges, this established player in the Medical Instruments &..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unveiling a 42.72% Potential Upside for Investors

For investors seeking opportunities in the healthcare sector, IQVIA Holdings, Inc. (IQV) presents a compelling case. With a market capitalization of $27.24 billion, IQVIA is a prominent player in the..

Abbott Laboratories (ABT) Stock Analysis: Unlocking a 30% Potential Upside for Investors

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a formidable presence in the medical devices industry, presents an intriguing opportunity for investors. With a current market capitalization..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Complex Valuations Amid Healthcare Sector Shifts

Investors with a keen eye on the healthcare sector have their sights set on Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry. With a market..

Quest Diagnostics Incorporated (DGX)

⚠️ No article content returned.

..

Elevance Health, Inc. (ELV) Stock Analysis: A Strong Buy with 12% Potential Upside

As investors navigate the ever-evolving healthcare sector, Elevance Health, Inc. (NYSE: ELV) emerges as a noteworthy contender. Formerly known as Anthem, Inc., this Indianapolis-based healthcare giant operates through four key..

STERIS plc (STE) Stock Analysis: Exploring a Potential 25.92% Upside in the Healthcare Sector

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, specializes in providing comprehensive infection prevention products and services. With a market capitalization of $21.77 billion, STERIS operates globally..

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Analyzing the 32.56% Potential Upside

For investors seeking robust opportunities in the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) presents a compelling case with its significant potential upside of 32.56%. With a current market..

Agilent Technologies, Inc. (A): Investor Outlook on Robust Growth Potential and a 39% Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors keen on tapping into robust growth potential...

The Cigna Group (CI) Stock Analysis: Exploring a Potential 22.73% Upside for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, continues to stand out with its robust market presence and promising financial metrics. With a market cap of $72.68..

Stryker Corporation (SYK) Stock Analysis: A Promising 27.97% Potential Upside for Healthcare Investors

Stryker Corporation (SYK), a titan in the healthcare sector, specifically within the medical devices industry, stands out in the investment landscape with a market capitalization of $125.43 billion. Headquartered in..

Danaher Corporation (DHR) Stock Analysis: A 41% Upside Potential Awaits Investors

Danaher Corporation (NYSE: DHR), a leading name in the healthcare sector’s diagnostics and research industry, offers investors a promising opportunity with a substantial 41.12% potential upside based on the current..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds